FDA hearings leave doctors, patients in limbo on Avandia.
Eggertson
Laura
L
Woodward
Cal
C
D000086:Acetazolamide; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D000077154:Rosiglitazone; D056737:Safety-Based Drug Withdrawals; D045162:Thiazolidinediones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D000086:Acetazolamide